Open AccessPilot study of oral administration of a curcumin-phospholipid formulation for treatment of central serous chorioretinopathy
Author(s) -
F. Mazzolani
Publication year - 2012
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s31859
Subject(s) - medicine , visual acuity , ophthalmology , serous fluid , retinal pigment epithelium , retinal , optical coherence tomography , citicoline , pathology , pharmacology
The purpose of this open-label study was to investigate the effect of a curcumin-phospholipid (lecithin, Meriva(®)) formulation (Norflo(®) tablet) on visual acuity and retinal thickness in patients with acute or chronic central serous chorioretinopathy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom